Biological Changes After Liver Transplantation According to the Presence or Not of Graft Steatosis

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3562-3565

  Muscari, F ^a   Guinard, J P ^a   Foppa, B ^a   Trocard, P ^a   Danjoux, M ^b   Kamel, M S ^a   Duffas, J P ^a   Rostaing, L ^a   Fourtanier, G ^a   Suc, B ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 5; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER BIOPSY; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; REPERFUSION;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; FACTOR V; FATTY LIVER; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTHROMBIN TIME;

EID: 57549097631     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.087     Document Type: Article

References (18)

1. Consensus Conference. indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais des congrès: text of recommendations (long version). Liver Transpl 12 (2006) 998
2. Azoulay D., Samuel D., Castaing D., et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg 189 (1999) 584
3. Lopez-Navidad A., and Cabarello F. Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool. Clin Transplant 17 (2003) 308
4. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 9 (2003) 651
5. Wilson D.J., Fisher A., Das K., et al. Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 75 (2003) 1683
6. Fukumori T., Kato T., Levi D., et al. Use of older controlled non-heart-beating donors for liver transplantation. Transplantation 75 (2003) 1171
7. Afonso R.C., Saad W.A., Parra O.M., et al. Impact od steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 36 (2004) 909
8. Perez-Daga J.A., Santoyo J., Suarez M.A., et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 38 (2006) 2468
9. Vetelainen R., Van Vliet A., Gouma D.J., et al. Steatosis as a risk factor in liver surgery. Ann Surg 245 (2007) 20
10. Pokorny H., Langer F., Herkner H., et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 19 (2005) 532
11. Zamboni F., Franchello A., David E., et al. Effect of macrovesicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 (2001) 53
12. Fernandez-Merino F.J., Nuno-Garza J., Lopez-Hervas P., et al. Imapct of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc 35 (2003) 1793
13. Verran D., Kusyk T., Painter D., et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9 (2003) 500
14. Yoo H.Y., Molmenti E., and Thuluvath P.J. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 9 (2003) 72
15. Muscari F., Suc B., Aguirre J., et al. Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systemic temporary portacaval anastomosis a justified procedure?. Transplant Proc 37 (2005) 2159
16. Adani G.L., Baccarani U., Sainz-Barriga M., et al. The role of hepatic biopsy to detect macrovesicular steatosis during liver procurement. Transplant Proc 38 (2006) 1404
17. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745
18. Urena M.A., Ruiz-Delgado F.C., Gonzalez E.M., et al. Hepatic steatosis in liver transplantation donors: common feature of donor population?. World J Surg 22 (1998) 837